2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazine | 1101205-24-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazine
• CAS: 1101205-24-6
• 化学式: C₁₁H₁₇BN₂O₂
• 分子量: 220.079
• InChiKey: OCSJKXYKWMVZNJ-UHFFFAOYSA-N

物化性质

• 沸点：
  313.4±42.0 °C(Predicted)
• 密度：
  1.06±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.08
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.64
• 拓扑面积：
  44.2
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazine 以 1,4-二氧六环 为溶剂， 生成 4-(5-Methyl-pyrazin-2-yl)-2-(2-quinolin-2-yl-ethyl)-2,3-dihydro-isoindol-1-one
  参考文献：
  名称：

  NOVEL INHIBITOR COMPOUNDS OF PHOSPHODIESTERASE TYPE 10A

  摘要：

  本发明涉及新型的氨基甲酸酰胺化合物、含有它们的药物组合物及其在治疗中的应用。这些化合物具有宝贵的治疗特性，特别适用于治疗或控制神经疾病和精神疾病，用于改善与这些疾病相关的症状，并用于降低这些疾病的风险。

  公开号：

  US20130005705A1

文献信息

• Discovery of Tetrahydroquinoxalines as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the Second Bromodomain
  作者：Robert P. Law、Stephen J. Atkinson、Paul Bamborough、Chun-wa Chung、Emmanuel H. Demont、Laurie J. Gordon、Matthew Lindon、Rab K. Prinjha、Allan J. B. Watson、David J. Hirst

  DOI：10.1021/acs.jmedchem.7b01666

  日期：2018.5.24

  The bromodomain and extra-terminal domain (BET) family of proteins bind acetylated lysine residues on histone proteins. The four BET bromodomains—BRD2, BRD3, BRD4, and BRDT—each contain two bromodomain modules. BET bromodomain inhibition is a potential therapy for various cancers and immunoinflammatory diseases, but few reported inhibitors show selectivity within the BET family. Inhibitors with selectivity

  蛋白质的溴结构域和末端外结构域（BET）家族结合组蛋白上的乙酰化赖氨酸残基。四个BET溴结构域-BRD2，BRD3，BRD4和BRDT-每个都包含两个溴结构域模块。BET溴结构域抑制是多种癌症和免疫炎性疾病的潜在疗法，但很少有报道的抑制剂在BET家族中显示出选择性。需要对第一或第二溴结构域具有选择性的抑制剂以帮助研究这些结构域的生物学功能。重点文库筛选确定了一系列对BET家族（BD2）的第二个溴结构域具有选择性的四氢喹喔啉。模板的结构指导优化提高了效能，选择性和物理化学性质，最终产生了具有BD2选择性的强效BET抑制剂。
• Expanding the scope of the Cu assisted Suzuki–Miyaura reaction
  作者：Brendan M. Crowley、Craig M. Potteiger、James Z. Deng、Christopher K. Prier、Daniel V. Paone、Christopher S. Burgey

  DOI：10.1016/j.tetlet.2011.07.088

  日期：2011.9

  Recent advances in the development of the copper facilitated Suzuki-Miyaura reaction are described. Improvements include expansion of substrate scope to include aryl chlorides and polyhalo aryl boronates. It was found that use of S-Phos and X-Phos could accomplish the coupling of 2-pyridyl boronates to aryl chlorides and bromides in shorter reaction times and in higher yield than previously described with DPPF. (C) 2011 Elsevier Ltd. All rights reserved.
• Copper-Facilitated Suzuki Reactions: Application to 2-Heterocyclic Boronates
  作者：James Z. Deng、Daniel V. Paone、Anthony T. Ginnetti、Hideki Kurihara、Spencer D. Dreher、Steven A. Weissman、Shaun R. Stauffer、Christopher S. Burgey

  DOI：10.1021/ol802556f

  日期：2009.1.15

  The palladium-catalyzed Suzuki-Miyaura reaction has been utilized as one of the most powerful methods for C-C bond formation. However, Suzuki reactions of electron-deficient 2-heterocyclic boronates generally give low conversions and remain challenging. The successful copper(l) facilitated Suzuki coupling of 2-heterocyclic boronates that is broad in scope Is reported. Use of this methodology affords greatly enhanced yields of these notoriously difficult couplings. Furthermore, mechanistic investigations suggest a possible role of copper in the catalytic cycle.
• [EN] QUINOLINE COMPOUNDS AS INHIBITORS OF KRAS<br/>[FR] COMPOSÉS DE QUINOLÉINE UTILES EN TANT QU'INHIBITEURS DE KRAS
  申请人：[en]INCYTE CORPORATION

  公开号：WO2023064857A1

  公开（公告）日：2023-04-20

  Disclosed are compounds of Formula I, methods of using the compounds for inhibiting KRAS activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with KRAS activity such as cancer.
• WO2023/121238
  申请人：——

  公开号：——

  公开（公告）日：——